Navigation Links
Merriman Curhan Ford Acted as Placement Agent in GenVec's $28 Million Registered Offering
Date:2/1/2010

been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal cancer, and head and neck cancer. In addition, GenVec uses its proprietary  adenovector technology  to develop vaccines for infectious diseases including influenza, HIV, malaria, foot-and-mouth disease, respiratory syncytial virus (RSV), and HSV-2. GenVec also discovers and develops novel treatments for hearing loss and balance disorders through a worldwide collaboration with Novartis. Additional information about GenVec is available at www.genvec.com and in the company's various filings with the Securities and Exchange Commission.

About Merriman Curhan Ford

Merriman Curhan Ford (NASDAQ: MERR) is a financial services firm focused on fast-growing companies and the institutions that invest in them. The company offers high-quality investment banking, equity research, institutional services and corporate & venture services, and specializes in five growth industry sectors: CleanTech, Consumer, Media & Internet, Health Care, Natural Resources and Technology.  For more information, please go to www.mcfco.com.

Note'/>"/>

SOURCE Merriman Curhan Ford
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Merriman Curhan Ford Acted as Lead Placement Agent in PolyMedixs $20.7 Million Equity Financing
2. Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th
3. Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009
4. ProMetic to present at Merriman Curhan Fords Investor Summit 2008 on September 16th
5. Bionovo to Present at Merriman Curhan Fords Investor Summit 2008 on September 15th
6. SuperGen to Present at Merriman 5th Annual Investor Summit on September 15, 2008
7. Solta Medical to Raise $17.2 Million in Private Placement
8. KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals
9. Encorium Group, Inc. Completes $1.6 Million Private Placement of Common Stock and Executes Warrant Exchange Agreement; Ends Discussions to Sell Encorium OY
10. Helix BioPharma Closes Private Placement
11. Building better bone replacements with bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... QUEBEC CITY , July 29, 2015 /PRNewswire/ ... (the "Company") today announced it has selected an optimized ... important milestone in the development of a new ... The MAPK pathway represents a prime target for ... significant antitumor activities and survival benefits for B-Raf ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... Clinical, a Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi LifeSciences ... recruitment services. The core expertise of PRC Clinical is focused on Clinical Trial ...
(Date:7/29/2015)... ... , ... Costello served as Lead Levee Design Engineering Manager for a feasibility ... area from future storm surge flooding, such as occurred in Hurricane Ike in 2008. ... for providing protection, Costello also balanced socio-economic and environmental needs and concerns. ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... says the company is making good progress in evaluating the full range of ... tissue stem cells. Adult tissue stem cells perform the day-to-day renewal and repair ...
Breaking Biology Technology:Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Preventing Storm Surge Flooding in Houston 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4
... , Purpose ... several different metabolite identification approaches are evaluated for their merits. A ... performed to illustrate data quality and types of metabolites found. A ... to create a thorough investigation of the metabolites derived from glyburide. ...
... , This application note describes ... software for Phase I and Phase II metabolite identification and discusses its ... Overview , ... more emphasis on characterization of potential drug candidates earlier in the discovery ...
... Specifications , Accelerating Your Research with the BD ... , . , ... new BD High Throughput Sampler (HTS) provides fully automated and rapid sample acquisition. ... sample carryover tolerances of 1% or less. The BD HTS adapts to ...
Cached Biology Technology:Strategies to Identify and Confirm Phase I Metabolites of Glyburide Using the 4000 Q TRAP System 2Strategies to Identify and Confirm Phase I Metabolites of Glyburide Using the 4000 Q TRAP System 3Strategies to Identify and Confirm Phase I Metabolites of Glyburide Using the 4000 Q TRAP System 4Strategies to Identify and Confirm Phase I Metabolites of Glyburide Using the 4000 Q TRAP System 5Strategies to Identify and Confirm Phase I Metabolites of Glyburide Using the 4000 Q TRAP System 6Identification of Phase I and Phase II Metabolites of Buspirone on the Q TRAP LC/MS/MS System 2Identification of Phase I and Phase II Metabolites of Buspirone on the Q TRAP LC/MS/MS System 3Identification of Phase I and Phase II Metabolites of Buspirone on the Q TRAP LC/MS/MS System 4Identification of Phase I and Phase II Metabolites of Buspirone on the Q TRAP LC/MS/MS System 5Technical Specifications, Accelerating Your Research with the BD FACSCanto, High Throughput Sampler Option 2Technical Specifications, Accelerating Your Research with the BD FACSCanto, High Throughput Sampler Option 3
(Date:7/2/2015)... , June 25, 2015 ... announced the addition of the "Natural Language ... Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) ... their offering. The key vendors occupying ... HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS ...
(Date:6/29/2015)... , June 24, 2015 ... addition of the "Latin America Biomedical Sensors Market ... their offering. The Latin America Biomedical Sensors ... a CAGR of 2.04% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
(Date:6/24/2015)... The biologics safety testing market is growing ... market include growth of the pharmaceutical and biological industries ... the years, the number of drug approvals in North ... FDA approved 225 drug applications and Health Canada approved ... accounted for 3,822 of the pharmaceutical and ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... tracking of threatened loggerhead sea turtles has revealed two previously ... providing important habitat for at least three separate populations of ... journal Biological Conservation . The two sites, ... Florida and the northern tip of the Yucatan Peninsula, were ...
... Case Western Reserve University are joining forces to ... will investigate and develop better protection and treatment ... to sports, military service and automobile accidents. ... have collaborated on state-of-the-art research in collision sports. ...
... -- Think of it as cooking with carbon spaghetti: ... to create and work with carbon nanotubes -- ultrasmall ... These carbon nanotubes -- made of graphene, an ... for improving laser detectors and rechargeable batteries, according to ...
Cached Biology News:Satellite tracking reveals sea turtle feeding hotspots 2Satellite tracking reveals sea turtle feeding hotspots 3Cleveland Clinic, Case Western Reserve University form research consortium 2Cleveland Clinic, Case Western Reserve University form research consortium 3The right recipe: Engineering research improves laser detectors, batteries 2The right recipe: Engineering research improves laser detectors, batteries 3
... does for enzyme-/substrate-based blotting what intensifying screens do ... up to 10-fold (or one order of magnitude) ... Signal Enhancer membrane treatment is a simple, 15-minute ... current Western blotting protocol. The result is an ...
...
... Expression is a revolutionary new ... analysis. Utilising a novel interface, Expression ... information incredibly simple. Expression uses the ... new standards in the way sequences ...
... Solution is a comprehensive suite of ... specifically designed to reliably extract biological ... genomic studies containing thousands of samples, ... efficient and will analyze large data ...
Biology Products: